Updated:
Roche
Roche family office in France manages the Hoffmann and Oeri families' pharmaceutical fortune across equities, private equity, and real estate.
Roche
The Roche family office operates as the private investment vehicle for descendants of the founding families behind F. Hoffmann-La Roche, the Swiss pharmaceutical giant established in 1896. The office is headquartered in France rather than Switzerland, though the wealth originates from the Roche Group, where the Hoffmann and Oeri families collectively hold a controlling stake through a vehicle known as the Château Sélection trust structure. The office allocates capital across a diversified portfolio including public equities, private equity, real estate, and alternative investments. While specific holdings are not publicly disclosed, family offices serving the Roche dynasty have historically maintained direct real estate positions in Switzerland and France, alongside indirect exposures via fund of funds. The office tends to avoid concentrated sector bets, instead favoring broad diversification. Geographic focus centers on Western Europe with selective exposure to North American and Asian markets. Total AUM remains undisclosed, and the office does not publish team size or office locations beyond France. The family offices aligned with the Roche group have been known to hold real estate assets through separate entities. A recent operational datum is unavailable: no verifiable public event from the last 24 months has been independently reported. The family's philanthropic arm, the Fondation Hoffmann-La Roche, operates separately from the direct family office, funding biomedical research and cultural initiatives. The structural differentiator for this office lies in its interstate duality: the wealth is Swiss pharmaceutical, but the family office sits in France, likely shaped by tax and privacy considerations. The office operates as a confidential single-family entity with no external capital or co-investment vehicle, maintaining a low public profile consistent with European family office norms. Its governance is not publicly documented.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
France
City
—
Corporate office
France
Frequently asked questions
Who are the beneficiaries of the Roche family office?
The office serves the Hoffmann and Oeri families, descendants of Fritz Hoffmann-La Roche, who founded F. Hoffmann-La Roche in 1896. The families collectively control a majority stake in the Roche Group through a holding structure. The specific individuals acting as beneficiaries are not publicly named.
How is the Roche family office structured legally?
The office is believed to be a single-family office registered in France. The broader Roche family holdings involve layered entities: the Château Sélection trust structure holds the families' stake in Roche Holding AG, while separate French entities manage direct investments. Detailed legal structures are not publicly available.
Does the Roche family office invest in external funds or direct deals?
Based on public record, the office uses a blend of fund-of-funds and direct investments. Family offices of the Roche dynasty have been noted in reporting to maintain direct real estate holdings and private equity fund commitments. The office does not operate a public co-investment vehicle.
What is the relationship between the Roche family office and the pharmaceutical company?
The family office is separate from F. Hoffmann-La Roche AG. The families control a majority voting stake in Roche Holding AG via a classified share structure (non-voting equity shares and bearer shares). The office invests the families' personal wealth independently of the company's corporate treasury.
Does the family office have a philanthropic branch?
Yes. The Fondation Hoffmann-La Roche, headquartered in Basel, is the family's philanthropic entity. It funds scientific research and culture, but operates separately from the investment office in France. The foundation's assets are distinct from the family office's portfolio.
Why is the Roche family office based in France rather than Switzerland?
The specific rationale is not publicly documented. It may relate to personal residence of family members, tax optimization, or privacy considerations. The Swiss portion of the family's wealth management is handled by other offices, including those in Basel.
What is the typical investment horizon for the Roche family office?
Given its single-family office structure and long-term wealth preservation mandate, the office likely operates with a multi-decade horizon reflecting the family's permanent capital base. Specific holding periods are not disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: